Clinical Trial Update: Dovitinib in Adenoid Cystic Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating dovitinib in Adenoid Cystic Carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma

Drugs mentioned

• Dovitinib (dovitinib)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Adenoid Cystic Carcinoma | Phase 2 | Status: COMPLETED